Survivin, Ki-67 and tumor grade as predictors of response to docetaxel-based neoadjuvant chemotherapy in locally advanced breast cancer

The response rates to neoadjuvant chemotherapy (NAC) in patients with locally advanced breast cancer (LABC) may vary and the risks may outweigh the benefits in poorly selected patients. This study investigated whether survivin expression, high-level Ki-67 expression, estrogen-receptor (ER) tumor sta...

Descripción completa

Detalles Bibliográficos
Autores principales: LIN, QI, LIU, YANG, CHEN, HUIYU, LIU, YI, TANG, QIANG, LIU, JING, CHEN, HAO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915650/
https://www.ncbi.nlm.nih.gov/pubmed/24649257
http://dx.doi.org/10.3892/mco.2013.138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915650/
https://www.ncbi.nlm.nih.gov/pubmed/24649257
http://dx.doi.org/10.3892/mco.2013.138

Ejemplares similares